Literature DB >> 16086736

Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases.

N Komatsu1, K Saijoh, T Toyama, R Ohka, N Otsuki, G Hussack, K Takehara, E P Diamandis.   

Abstract

BACKGROUND: Human tissue kallikreins are a gene family (KLK1-KLK15) encoding for 15 secretory serine proteases (hK1-hK15). Two tissue kallikrein proteins, hK5 and hK7, were previously found in the stratum corneum (SC), stratum granulosum (SG) and appendages. hK8 was also shown to be secreted via lamellar granules and numerous KLK mRNAs were previously identified. KLKs are believed to be responsible for desquamation of corneocytes and sebum, sweat and hair maturation.
OBJECTIVES: To demonstrate immunohistochemically the expression of hK6, hK8 and hK13 in normal skin tissue and to show an increased cell number expressing kallikrein mRNAs and proteins in psoriasis vulgaris (PV) and atopic dermatitis (AD).
METHODS: Samples of normal, PV and AD skin were obtained. hK6-, hK8- and hK13-specific antibodies were produced and used for immunohistochemical analysis. Multiple KLK mRNAs were synthesized and used for in situ hybridization study.
RESULTS: Three other hKs, namely hK6, hK8 and hK13, were immunohistochemically identified as new skin serine proteases in the whole SC, SG, sebaceous glands, eccrine sweat glands, hair follicles and nerves. We also demonstrated an increased number of cells expressing KLK mRNAs and hKs in PV and AD. In PV, KLK mRNAs/hKs were predominantly expressed in the upper epidermis. In AD, hK distribution was rather diffuse and expanded into the lower epidermis.
CONCLUSIONS: The colocalization of various hKs seems to be essential for the regulation of serine protease activity in skin and for steady desquamation and skin barrier function. Moreover, the increased number of cells expressing multiple KLK mRNA and hK in PV and AD could be a clue to elucidate their pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086736     DOI: 10.1111/j.1365-2133.2005.06754.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  28 in total

1.  Culture, immortalization, and characterization of human meibomian gland epithelial cells.

Authors:  Shaohui Liu; Mark P Hatton; Payal Khandelwal; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-24       Impact factor: 4.799

2.  LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction.

Authors:  Celine Deraison; Chrystelle Bonnart; Frederic Lopez; Celine Besson; Ross Robinson; Arumugam Jayakumar; Fredrik Wagberg; Maria Brattsand; Jean Pierre Hachem; Goran Leonardsson; Alain Hovnanian
Journal:  Mol Biol Cell       Date:  2007-06-27       Impact factor: 4.138

Review 3.  New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.

Authors:  Nashmil Emami; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2007-09-15       Impact factor: 6.603

Review 4.  Unleashing the therapeutic potential of human kallikrein-related serine proteases.

Authors:  Ioannis Prassas; Azza Eissa; Gennadiy Poda; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

5.  Skin barrier defects in atopic dermatitis.

Authors:  Rachana Agrawal; Judith A Woodfolk
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

6.  Transition to an Aquatic Habitat Permitted the Repeated Loss of the Pleiotropic KLK8 Gene in Mammals.

Authors:  Nikolai Hecker; Virag Sharma; Michael Hiller
Journal:  Genome Biol Evol       Date:  2017-11-01       Impact factor: 3.416

7.  Characterization of Spink6 in mouse skin: the conserved inhibitor of kallikrein-related peptidases is reduced by barrier injury.

Authors:  Jan Fischer; Zhihong Wu; Tomasz Kantyka; Maria Sperrhacke; Olga Dimitrieva; Yulia Koblyakova; Kerstin Ahrens; Nina Graumann; Hansjörg Baurecht; Karina Reiss; Jens-Michael Schröder; Ehrhardt Proksch; Ulf Meyer-Hoffert
Journal:  J Invest Dermatol       Date:  2013-11-22       Impact factor: 8.551

8.  Expression of Protease-Activated Receptor-2 in SZ95 Sebocytes and its Role in Sebaceous Lipogenesis, Inflammation, and Innate Immunity.

Authors:  Sang E Lee; Ji-Min Kim; Se K Jeong; Eung H Choi; Christos C Zouboulis; Seung H Lee
Journal:  J Invest Dermatol       Date:  2015-04-16       Impact factor: 8.551

Review 9.  Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis.

Authors:  Sang Eun Lee; Se Kyoo Jeong; Seung Hun Lee
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

10.  Quantification of Human Kallikrein-Related Peptidases in Biological Fluids by Multiplatform Targeted Mass Spectrometry Assays.

Authors:  Theano D Karakosta; Antoninus Soosaipillai; Eleftherios P Diamandis; Ihor Batruch; Andrei P Drabovich
Journal:  Mol Cell Proteomics       Date:  2016-07-01       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.